Logo image of LAIX

LAIX INC - ADR (LAIX) Stock Fundamental Analysis

USA - NYSE:LAIX - ADR

3.1
-0.33 (-9.62%)
Last: 4/7/2022, 8:04:00 PM
Fundamental Rating

2

Overall LAIX gets a fundamental rating of 2 out of 10. We evaluated LAIX against 75 industry peers in the Diversified Consumer Services industry. The financial health of LAIX is average, but there are quite some concerns on its profitability. LAIX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LAIX has reported negative net income.
LAIX Yearly Net Income VS EBIT VS OCF VS FCFLAIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 -100M -200M -300M -400M -500M

1.2 Ratios

Industry RankSector Rank
ROA -26.97%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LAIX Yearly ROA, ROE, ROICLAIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 100 -100 200 -200

1.3 Margins

Industry RankSector Rank
OM -10.58%
PM (TTM) -9.27%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LAIX Yearly Profit, Operating, Gross MarginsLAIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 -200 -400 -600

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, LAIX has more shares outstanding
LAIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LAIX Yearly Shares OutstandingLAIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 200M 400M 600M
LAIX Yearly Total Debt VS Total AssetsLAIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 200M 400M 600M 800M

2.2 Solvency

LAIX has an Altman-Z score of -9.28. This is a bad value and indicates that LAIX is not financially healthy and even has some risk of bankruptcy.
There is no outstanding debt for LAIX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.28
ROIC/WACCN/A
WACCN/A
LAIX Yearly LT Debt VS Equity VS FCFLAIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 200M -200M -400M -600M

2.3 Liquidity

A Current Ratio of 0.20 indicates that LAIX may have some problems paying its short term obligations.
A Quick Ratio of 0.20 indicates that LAIX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
LAIX Yearly Current Assets VS Current LiabilitesLAIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.21% over the past year.
The Revenue for LAIX has decreased by -13.96% in the past year. This is quite bad
LAIX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 198.20% yearly.
EPS 1Y (TTM)114.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.97%
Revenue 1Y (TTM)-13.96%
Revenue growth 3Y80.42%
Revenue growth 5Y198.2%
Sales Q2Q%-33.38%

3.2 Future

The Earnings Per Share is expected to grow by 14.84% on average over the next years. This is quite good.
The Revenue is expected to decrease by -13.75% on average over the next years. This is quite bad
EPS Next Y99.57%
EPS Next 2Y41.34%
EPS Next 3Y25.97%
EPS Next 5Y14.84%
Revenue Next Year-27.88%
Revenue Next 2Y-22.1%
Revenue Next 3Y-16.08%
Revenue Next 5Y-13.75%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LAIX Yearly Revenue VS EstimatesLAIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
LAIX Yearly EPS VS EstimatesLAIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LAIX. In the last year negative earnings were reported.
Also next year LAIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LAIX Price Earnings VS Forward Price EarningsLAIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -13.56
LAIX Per share dataLAIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8 -10

4.3 Compensation for Growth

LAIX's earnings are expected to grow with 25.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.34%
EPS Next 3Y25.97%

More info and screens

0

5. Dividend

5.1 Amount

LAIX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LAIX INC - ADR

NYSE:LAIX (4/7/2022, 8:04:00 PM)

3.1

-0.33 (-9.62%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)03-01 2022-03-01/amc
Earnings (Next)04-25 2022-04-25
Inst Owners4.6%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap154.68M
Analysts40
Price Target18.56 (498.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.16
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -13.56
EPS(TTM)-10.02
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.68
BVpS-2.13
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.97%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -10.58%
PM (TTM) -9.27%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z -9.28
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.97%
EPS Next Y99.57%
EPS Next 2Y41.34%
EPS Next 3Y25.97%
EPS Next 5Y14.84%
Revenue 1Y (TTM)-13.96%
Revenue growth 3Y80.42%
Revenue growth 5Y198.2%
Sales Q2Q%-33.38%
Revenue Next Year-27.88%
Revenue Next 2Y-22.1%
Revenue Next 3Y-16.08%
Revenue Next 5Y-13.75%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A